European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel-Reference-Cited by-同舟云学术

European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel

Published:2021-04 Issue:4 Volume:79 Page:480-488
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Sylvester Richard J.^ORCID,Rodríguez Oscar,Hernández Virginia,Turturica Diana,Bauerová Lenka,Bruins Harman Max,Bründl Johannes,van der Kwast Theo H.,Brisuda Antonin,Rubio-Briones José,Seles Maximilian,Hentschel Anouk E.,Kusuma Venkata R.M.,Huebner Nicolai,Cotte Juliette,Mertens Laura S.,Volanis Dimitrios,Cussenot Olivier,Subiela Henríquez Jose D.,de la Peña Enrique,Pisano Francesca,Pešl Michael,van der Heijden Antoine G.,Herdegen Sonja,Zlotta Alexandre R.,Hacek Jaromir,Calatrava Ana,Mannweiler Sebastian,Bosschieter Judith,Ashabere David,Haitel Andrea,Côté Jean-François,El Sheikh Soha,Lunelli Luca,Algaba Ferran,Alemany Isabel,Soria Francesco,Runneboom Willemien,Breyer Johannes,Nieuwenhuijzen Jakko A.,Llorente Carlos,Molinaro Luca,Hulsbergen-van de Kaa Christina A.,Evert Matthias,Kiemeney Lambertus A.L.M.,N’Dow James,Plass Karin,Čapoun Otakar,Soukup Viktor,Dominguez-Escrig Jose L.,Cohen Daniel,Palou Joan,Gontero Paolo,Burger Maximilian,Zigeuner Richard,Mostafid Amir Hugh,Shariat Shahrokh F.,Rouprêt Morgan,Compérat Eva M.,Babjuk Marko,van Rhijn Bas W.G.

Publisher

Elsevier BV

Subject

Urology

Reference33 articles.

1. Risk stratification tools and prognostic models in non–muscle-invasive bladder cancer: a critical assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel;Soukup;Eur Urol Focus,2020

2. European Association of Urology guidelines on non–muscle-invasive bladder cancer (TaT1 and carcinoma in situ): 2019 update;Babjuk;Eur Urol,2019

3. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials;Sylvester;Eur Urol,2006

4. Prognostic factors in patients with non–muscle-invasive bladder cancer treated with bacillus Calmette-Guerin: multivariable analysis of data from four randomized CUETO Trials;Fernandez-Gomez;Eur Urol,2008

5. Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model;Fernandez-Gomez;J Urol,2009

Cited by 250 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing efficacy and safety of in-house gemcitabine to mitomycin for bladder instillation in intermediate-risk NMIBC;The French Journal of Urology;2024-12

2. Can Bladder MRI Improve the Follow-Up of Non–Muscle-Invasive Bladder Cancer by Detecting Endoscopic Invisible Recurrence?;Clinical Genitourinary Cancer;2024-10

3. Neue Therapieansätze beim nicht-muskelinvasiven Urothelkarzinom der Harnblase – Ist der Organerhalt auch nach BCG (Bacillus Calmette-Guérin) möglich?;Die Urologie;2024-08-23

4. Multiparametric MRI‐Based Deep Learning Radiomics Model for Assessing 5‐Year Recurrence Risk in Non‐Muscle Invasive Bladder Cancer;Journal of Magnetic Resonance Imaging;2024-08-21

5. Prognostic significance of residual tumor at restaging transurethral bladder resection in high-risk non-muscle-invasive bladder cancer;World Journal of Urology;2024-08-12